reduction of oxidative damage
Easy access does not mean safe or appropriate for human use. The legality of it all So, how are pharmacies legally selling and distributing peptides on the restricted list
The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
Keeping that distinction in view prevents the most common error in this comparison: treating a standalone-monotherapy number for one and a combination number for the other as if they were measured the same way